Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching

James Trauer, Stephen Muhi, Emma S. McBryde, Shmeylan A. Al Harbi, Yaseen M. Arabi, Andrew J. Boyle, Rodrigo Cartin-Ceba, Wei Chen, Yung Tai Chen, Marco Falcone, Ognjen Gajic, Jack Godsell, Michelle Ng Gong, Daryl Kor, Wolfgang Lösche, Daniel F. McAuley, Hollis R. O'Neal, Michael Osthoff, Gordon P. Otto, Maik SossdorfMin Juei Tsai, Juan C. Valerio-Rojas, Tom van der Poll, Francesco Violi, Lorraine Ware, Andreas F. Widmer, Maryse A. Wiewel, Johannes Winning, Damon P. Eisen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

OBJECTIVE: The primary objective was to conduct a meta-analysis on published observational cohort data describing the association between acetyl-salicylic acid (aspirin) use prior to the onset of sepsis and mortality in hospitalized patients.

STUDY SELECTION: Studies that reported mortality in patients on aspirin with sepsis with a comparison group of patients with sepsis not on prior aspirin therapy were included.

DATA SOURCES: Fifteen studies described hospital-based cohorts (n = 17,065), whereas one was a large insurance-based database (n = 683,421). Individual-level patient data were incorporated from all selected studies.

DATA EXTRACTION: Propensity analyses with 1:1 propensity score matching at the study level were performed, using the most consistently available covariates judged to be associated with aspirin. Meta-analyses were performed to estimate the pooled average treatment effect of aspirin on sepsis-related mortality.

DATA SYNTHESIS: Use of aspirin was associated with a 7% (95% CI, 2-12%; p = 0.005) reduction in the risk of death as shown by meta-analysis with considerable statistical heterogeneity (I = 61.6%).

CONCLUSIONS: These results are consistent with effects ranging from a 2% to 12% reduction in mortality risk in patients taking aspirin prior to sepsis onset. This association anticipates results of definitive studies of the use of low-dose aspirin as a strategy for reduction of deaths in patients with sepsis.

Original languageEnglish (US)
Pages (from-to)1871-1879
Number of pages9
JournalCritical Care Medicine
Volume45
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Salicylic Acid
Aspirin
Meta-Analysis
Sepsis
Mortality
Propensity Score
Risk Reduction Behavior
Insurance
Databases
Therapeutics

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths : An Individual Patient Data Meta-Analysis Using Propensity Matching. / Trauer, James; Muhi, Stephen; McBryde, Emma S.; Al Harbi, Shmeylan A.; Arabi, Yaseen M.; Boyle, Andrew J.; Cartin-Ceba, Rodrigo; Chen, Wei; Chen, Yung Tai; Falcone, Marco; Gajic, Ognjen; Godsell, Jack; Gong, Michelle Ng; Kor, Daryl; Lösche, Wolfgang; McAuley, Daniel F.; O'Neal, Hollis R.; Osthoff, Michael; Otto, Gordon P.; Sossdorf, Maik; Tsai, Min Juei; Valerio-Rojas, Juan C.; van der Poll, Tom; Violi, Francesco; Ware, Lorraine; Widmer, Andreas F.; Wiewel, Maryse A.; Winning, Johannes; Eisen, Damon P.

In: Critical Care Medicine, Vol. 45, No. 11, 01.11.2017, p. 1871-1879.

Research output: Contribution to journalArticle

Trauer, J, Muhi, S, McBryde, ES, Al Harbi, SA, Arabi, YM, Boyle, AJ, Cartin-Ceba, R, Chen, W, Chen, YT, Falcone, M, Gajic, O, Godsell, J, Gong, MN, Kor, D, Lösche, W, McAuley, DF, O'Neal, HR, Osthoff, M, Otto, GP, Sossdorf, M, Tsai, MJ, Valerio-Rojas, JC, van der Poll, T, Violi, F, Ware, L, Widmer, AF, Wiewel, MA, Winning, J & Eisen, DP 2017, 'Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching', Critical Care Medicine, vol. 45, no. 11, pp. 1871-1879. https://doi.org/10.1097/CCM.0000000000002654
Trauer, James ; Muhi, Stephen ; McBryde, Emma S. ; Al Harbi, Shmeylan A. ; Arabi, Yaseen M. ; Boyle, Andrew J. ; Cartin-Ceba, Rodrigo ; Chen, Wei ; Chen, Yung Tai ; Falcone, Marco ; Gajic, Ognjen ; Godsell, Jack ; Gong, Michelle Ng ; Kor, Daryl ; Lösche, Wolfgang ; McAuley, Daniel F. ; O'Neal, Hollis R. ; Osthoff, Michael ; Otto, Gordon P. ; Sossdorf, Maik ; Tsai, Min Juei ; Valerio-Rojas, Juan C. ; van der Poll, Tom ; Violi, Francesco ; Ware, Lorraine ; Widmer, Andreas F. ; Wiewel, Maryse A. ; Winning, Johannes ; Eisen, Damon P. / Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths : An Individual Patient Data Meta-Analysis Using Propensity Matching. In: Critical Care Medicine. 2017 ; Vol. 45, No. 11. pp. 1871-1879.
@article{297b6ac568f248308b6c33b00fe6ae54,
title = "Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching",
abstract = "OBJECTIVE: The primary objective was to conduct a meta-analysis on published observational cohort data describing the association between acetyl-salicylic acid (aspirin) use prior to the onset of sepsis and mortality in hospitalized patients.STUDY SELECTION: Studies that reported mortality in patients on aspirin with sepsis with a comparison group of patients with sepsis not on prior aspirin therapy were included.DATA SOURCES: Fifteen studies described hospital-based cohorts (n = 17,065), whereas one was a large insurance-based database (n = 683,421). Individual-level patient data were incorporated from all selected studies.DATA EXTRACTION: Propensity analyses with 1:1 propensity score matching at the study level were performed, using the most consistently available covariates judged to be associated with aspirin. Meta-analyses were performed to estimate the pooled average treatment effect of aspirin on sepsis-related mortality.DATA SYNTHESIS: Use of aspirin was associated with a 7{\%} (95{\%} CI, 2-12{\%}; p = 0.005) reduction in the risk of death as shown by meta-analysis with considerable statistical heterogeneity (I = 61.6{\%}).CONCLUSIONS: These results are consistent with effects ranging from a 2{\%} to 12{\%} reduction in mortality risk in patients taking aspirin prior to sepsis onset. This association anticipates results of definitive studies of the use of low-dose aspirin as a strategy for reduction of deaths in patients with sepsis.",
author = "James Trauer and Stephen Muhi and McBryde, {Emma S.} and {Al Harbi}, {Shmeylan A.} and Arabi, {Yaseen M.} and Boyle, {Andrew J.} and Rodrigo Cartin-Ceba and Wei Chen and Chen, {Yung Tai} and Marco Falcone and Ognjen Gajic and Jack Godsell and Gong, {Michelle Ng} and Daryl Kor and Wolfgang L{\"o}sche and McAuley, {Daniel F.} and O'Neal, {Hollis R.} and Michael Osthoff and Otto, {Gordon P.} and Maik Sossdorf and Tsai, {Min Juei} and Valerio-Rojas, {Juan C.} and {van der Poll}, Tom and Francesco Violi and Lorraine Ware and Widmer, {Andreas F.} and Wiewel, {Maryse A.} and Johannes Winning and Eisen, {Damon P.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1097/CCM.0000000000002654",
language = "English (US)",
volume = "45",
pages = "1871--1879",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths

T2 - An Individual Patient Data Meta-Analysis Using Propensity Matching

AU - Trauer, James

AU - Muhi, Stephen

AU - McBryde, Emma S.

AU - Al Harbi, Shmeylan A.

AU - Arabi, Yaseen M.

AU - Boyle, Andrew J.

AU - Cartin-Ceba, Rodrigo

AU - Chen, Wei

AU - Chen, Yung Tai

AU - Falcone, Marco

AU - Gajic, Ognjen

AU - Godsell, Jack

AU - Gong, Michelle Ng

AU - Kor, Daryl

AU - Lösche, Wolfgang

AU - McAuley, Daniel F.

AU - O'Neal, Hollis R.

AU - Osthoff, Michael

AU - Otto, Gordon P.

AU - Sossdorf, Maik

AU - Tsai, Min Juei

AU - Valerio-Rojas, Juan C.

AU - van der Poll, Tom

AU - Violi, Francesco

AU - Ware, Lorraine

AU - Widmer, Andreas F.

AU - Wiewel, Maryse A.

AU - Winning, Johannes

AU - Eisen, Damon P.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - OBJECTIVE: The primary objective was to conduct a meta-analysis on published observational cohort data describing the association between acetyl-salicylic acid (aspirin) use prior to the onset of sepsis and mortality in hospitalized patients.STUDY SELECTION: Studies that reported mortality in patients on aspirin with sepsis with a comparison group of patients with sepsis not on prior aspirin therapy were included.DATA SOURCES: Fifteen studies described hospital-based cohorts (n = 17,065), whereas one was a large insurance-based database (n = 683,421). Individual-level patient data were incorporated from all selected studies.DATA EXTRACTION: Propensity analyses with 1:1 propensity score matching at the study level were performed, using the most consistently available covariates judged to be associated with aspirin. Meta-analyses were performed to estimate the pooled average treatment effect of aspirin on sepsis-related mortality.DATA SYNTHESIS: Use of aspirin was associated with a 7% (95% CI, 2-12%; p = 0.005) reduction in the risk of death as shown by meta-analysis with considerable statistical heterogeneity (I = 61.6%).CONCLUSIONS: These results are consistent with effects ranging from a 2% to 12% reduction in mortality risk in patients taking aspirin prior to sepsis onset. This association anticipates results of definitive studies of the use of low-dose aspirin as a strategy for reduction of deaths in patients with sepsis.

AB - OBJECTIVE: The primary objective was to conduct a meta-analysis on published observational cohort data describing the association between acetyl-salicylic acid (aspirin) use prior to the onset of sepsis and mortality in hospitalized patients.STUDY SELECTION: Studies that reported mortality in patients on aspirin with sepsis with a comparison group of patients with sepsis not on prior aspirin therapy were included.DATA SOURCES: Fifteen studies described hospital-based cohorts (n = 17,065), whereas one was a large insurance-based database (n = 683,421). Individual-level patient data were incorporated from all selected studies.DATA EXTRACTION: Propensity analyses with 1:1 propensity score matching at the study level were performed, using the most consistently available covariates judged to be associated with aspirin. Meta-analyses were performed to estimate the pooled average treatment effect of aspirin on sepsis-related mortality.DATA SYNTHESIS: Use of aspirin was associated with a 7% (95% CI, 2-12%; p = 0.005) reduction in the risk of death as shown by meta-analysis with considerable statistical heterogeneity (I = 61.6%).CONCLUSIONS: These results are consistent with effects ranging from a 2% to 12% reduction in mortality risk in patients taking aspirin prior to sepsis onset. This association anticipates results of definitive studies of the use of low-dose aspirin as a strategy for reduction of deaths in patients with sepsis.

UR - http://www.scopus.com/inward/record.url?scp=85032159686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032159686&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000002654

DO - 10.1097/CCM.0000000000002654

M3 - Article

C2 - 28799949

AN - SCOPUS:85032159686

VL - 45

SP - 1871

EP - 1879

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 11

ER -